𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunological aspects of benign melanocytic tumours and melanoma in situ

✍ Scribed by Neil I. Wilson; Alistair J. Cochran; Catherine E. Ross; Rona M. Mackie; Lindsay J. Ogg; Gaye Todd


Book ID
104663845
Publisher
Springer-Verlag
Year
1979
Tongue
English
Weight
583 KB
Volume
6
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Immunoreactivity of Ξ±-melanocyte-stimula
✍ Nagahama; Funasaka; Fernandez-Frez; Ohashi; Chakraborty; Ueda; Ichihashi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 524 KB

Melanocyte-stimulating hormone (MSH) has been reported to enhance the experimental metastatic behaviour of melanoma cells in the mouse model. alpha-MSH production and MSH receptor (melanocortin 1 receptor gene) expression have been detected in cultured normal human melanocytes and metastasized melan

An immunological aspect of melanoma and
✍ E. George Elias; Vesna J. Tomazic πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 359 KB

In an attempt to understand some of the natural immunological characteristics of cutaneous melanoma so that we can plan justifiable immunotherapeutic approaches, 23 patients were studied. The autologous leukocyte migration inhibition assay was utilized to assess in vitro their tumor-specific cellula

In situ repair of cyclobutane pyrimidine
✍ Chunyan Zhao; Erna Snellman; Christer T. Jansen; Kari Hemminki πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 129 KB

## Abstract The development of cutaneous malignant melanoma (CMM) and its precursor lesions, melanocytic nevi, has been linked to sun exposure. Cyclobutane pyrimidine dimers (CPDs) are the majority of DNA lesions induced by sun exposure. In our study, we investigated if CMM patients have impaired a